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Background: The purpose of the study was to analyze the characteristics and evolution of non-invasive mechanical
ventilation (NIV) in the postoperative period of heart surgery in children.
Methods: Retrospective observational study including all children requiring NIV after heart surgery in a single center
pediatric intensive care unit (PICU) between 2001 and 2012. Demographic characteristics, ventilation parameters and
outcomes were registered, comparing the first 6 years of the study with the last 6 years.
Results: 935 children required invasive or non-invasive mechanical ventilation, of which 200 (21.4) received NIV. The
median duration of NIV was 3 days. Mortality rate was 3.9%. The use of NIV increased from 13.2% in the first period to
29.2% in the second period (p <0.001). Continuous positive airway pressure (CPAP) was the most common modality of
NIV (65.5%). The use of bilevel positive airway pressure mode (BIPAP) increased from 15% in the first period to 42.9% in
the second period (p < 0.001). The nasopharyngeal tube was the most common interface (66%), but the use of nasal
cannula increased from 3.3 to 41.4% in the second period (p < 0.001). NIV failed in 15% of patients. The mortality rate
did not change, the duration of NIV decreased and the PICU length of stay increased throughout the study.
Conclusions: NIV is increasingly being used in the postoperative period of heart surgery in our center with an 85%
success rate and is associated with a lesser need for invasive mechanical ventilation. CPAP was the most common
modality and the “nasopharyngeal tube” was the most common interface in our study although, in the latter years, the
use of BIPAP and nasal cannula has increased significantly.
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Outcomes in children after heart surgery depend on the
severity and complexity of the underlying heart disease,
preexisting conditions, duration and complications
during surgery and clinical evolution in the postopera-
tive period [1].
The use of mechanical ventilation in the postoperative
period has an important impact on hemodynamics and
clinical evolution [2, 3]. Several studies have found an
association between mechanical ventilation in children
after heart surgery and an increased risk of mortality,
longer pediatric intensive care unit (PICU) length of stay
(LOS) and greater costs [4, 5].* Correspondence: sarahlafever@gmail.com; pielvi@hotmail.com
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mended if the hemodynamic situation after surgery is
acceptable [6]. Several studies have analyzed the factors
that are associated with a prolonged extubation after
heart surgery in children [7, 8], but there are no studies
that analyze whether there is an association between
NIV and the duration of invasive mechanical ventilation
(IMV) and PICU LOS.
The aim of this study was to analyze the characteris-
tics and evolution of pediatric patients treated with NIV
after heart surgery.Methods
A retrospective review examined the medical records of all
patients between 3 days and 16 years of age requiring IMV
or NIV after heart surgery in a single center PICU between
the 1st of January 2001 and the 31st of December 2012.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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sity Hospital Research Ethics Committee. The physician in
charge of the patient established the indication and the set-
tings of mechanical ventilation (NIV and IMV).
The following data were collected from each patient:
age, sex, indication and duration of IMV and NIV, mo-
dality of NIV, continuous positive airway pressure
(CPAP) or bilevel positive airway pressure (BIPAP),
interface (nasal cannula, endotracheal tube in a nasopha-
ryngeal position (“nasopharyngeal tube”), nasal mask or
full face mask), NIV failure, mortality and PICU LOS.
Some authors discuss whether CPAP should be consid-
ered as non-invasive mechanical ventilation but, in this
study, CPAP and BIPAP are considered non-invasive
modalities of mechanical ventilation.
The indication of NIV was classified into two
groups: prophylactic, immediately after extubation and
non-prophylactic (patients with acute respiratory fail-
ure (ARF)). Specific scales of respiratory distress were
not used. The presence of respiratory failure as well
as the need for intubation were based on the
physician-in-charge’s assessment of the patient.
The study period was divided into two groups (the first
6 years and the second 6 years) in order to study the evo-
lution of respiratory support.
Diaphragmatic paralysis is defined as unilateral or bi-
lateral dysfunction of the diaphragm. Initial suspicion
was based on X-Ray findings (elevated diaphragm) or
clinical findings (asymmetrical hemithorax excursion,
abnormal breathing pattern using accessory respiratory
muscles and paradoxical abdominal wall retraction dur-
ing inspiration). Clinical suspicion was confirmed with
M-mode ultrasonography and electromyography.
The program SPSS 18.0 was used for data analysis.
Quantitative variables are expressed as medians and
interquartile ranges (IQR) as data do not follow a nor-
mal distribution, and non-parametric tests were used for
comparisons (Chi-square test for randomness with cat-
egorical outcomes, Man-Whitney test for comparing
quantitative variables between two groups and Kruskal-
Wallis test for comparing quantitative variables between
more than two groups). A p value less than 0.05 was
considered statistically significant.
Results
Nine hundred and thirty five patients between 3 days
and 16 years of age required mechanical support after
heart surgery, with a median age of 9 months (IQR 4.0–
60.0). 59.1% were males. The median duration of IMV
was 1.5 days (IQR 0.5–7.0). The median LOS was
7.0 days (4.0–15.0), with a mortality rate of 3.9%. 200 pa-
tients required NIV (21.4%) and 153 patients (16.4%)
received both IMV and NIV. Mean duration of NIV was
3 days (IQR 2.0–5.0).Characteristics of non invasive mechanical ventilation
Prophylactic NIV was the most common indication
(67%), followed by ARF (33%). CPAP was the most
common modality of NIV (65.5%) and the “nasopharyn-
geal tube” was the most common interface (66%),
followed by nasal cannula (30%), full face mask (3.5%)
and nasal mask (3%).
The median age of children with NIV was 6 months
(IQR 3.0–24.0), the duration of IMV was 8 days (4.0–
14.5), PICU LOS was 17 days (9.0–32.0) and mortality
rate was 3.4% (8 patients).
Evolution of non invasive mechanical ventilation
The study period was divided into two groups (the first
6 years and the second 6 years) in order to study the evolu-
tion of respiratory support (Table 1). The number of
patients in each study period was very similar. The use of
IMV decreased significantly and NIV increased in the sec-
ond period, with no variations in its indication. There were
no significant differences in mortality between both periods
(3.7 vs 4.0%, p = 0.867) but mortality tended to decrease in
patients with NIV (5.8% vs 2.4%, p = 0.239). The use of bile-
vel positive airway pressure mode (BIPAP) increased from
15% in the first period to 42.9% in the second period (p <
0.001). The nasopharyngeal tube was the most common
interface (66%), but the use of nasal cannula increased from
3.3 to 41.4% in the second period (p < 0.001), with a signifi-
cant decrease in the use of nasal masks. The duration of
NIV and the PICU LOS in patients with NIV significantly
decreased in the second period. The use of NIV signifi-
cantly increased throughout the study period (p <0.001)
(Fig. 1). There was a trend toward a higher RACHS score
in patients requiring NIV in the second period of the study
(2.0 [2.0–3.0] vs 3.0 [2.0–3.0]) as were the number of heart
transplants (8 vs 13), although these results were not statis-
tically significant (p = 0.91 and p = 0.452, respectively).
Comparison between invasive and non invasive
mechanical ventilation
PICU LOS in patients receiving only IMV (5.0, IQR 3.0–
10.0) was significantly lower than those with only NIV
(7.0, IQR 6.0–13.0; p 0.001). PICU LOS of patients requir-
ing both IMV and NIV (19.0, IQR 11.0–32.5) was signifi-
cantly higher than those with only IMV or NIV (p 0.001).
There was a trend to a higher mortality rate in patients
receiving only IMV (4.8%) than those receiving NIV
(0.0%) or both (3.2%), but differences were not signifi-
cant (p 0.274).
Comparison according to age, indication and type of
non-invasive mechanical ventilation
The median age of children with prophylactic NIV
(18.5 months), with CPAP (8.4 months) and “nasopha-
ryngeal tube” (6.9 months) was significantly lower than
Table 1 Comparison between study periods
2001–2006% (n) 2007–2012 p
Number of patients 48.7% (455/935) 51.3% (480/935)
Age (months) 7 (IQR 4–48) 12 (IQR 5–60) <0.001
IMV 96.7% (440/455) 93.3% (448/480) <0.001
NIV 13.2% (60/455) 29.2% (140/480) <0.001
NIV only 25% (15/60) 22.9% (32/140) 0.321
NIV indication
- Prophylactic 65% (39/60) 67.9% (95/140) 0.744
- Acute Respiratory Failure 35% (21/60) 32.1% (45/140)
NIV type
- CPAP 85% (51/60) 57.1% (80/140) 0.001
- BIPAP 15% (9/60) 42.9% (60/140)
Interface
- Nasopharingeal tuve 85% (51/60) 57.9% (81/140) 0.001
- Nasal mask 10% (6/60) 0.7% (1/140) 0.003
- Full face mask 1.6% (1/60) 3.5% (5/140) 0.417
- Nasal cannula 3.3% (2/60) 41.4% (58/140) 0.001
NIV failure 20% (12/60) 12.9% (18/140) 0.201
Mortality 3.7% (17/455) 4.0% (19/480) 0.867
Median (IQR) Median (IQR)
Duration of IMV (days) 1.0 (0.5–6.0) 2.0 (0.75–7.0) 0.139
Duration of NIV (days) 3.0 (2.0–5.0) 2.0 (1.0–4.5) 0.024
PICU LOS All patients (days) 6.0 (4.0–14.0) 7.0 (4.0–15.7) 0.053
PICU LOS Patients NIV (days) 22.0 (9.0–35.0) 14.0 (8.0–23.0) 0.004
BIPAP bilevel positive airway pressure, CPAP continuous positive airway
pressure, IMV invasive mechanical ventilation, NIV non-invasive ventilation,
PICU LOS pediatric intensive care unit length of stay
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(33.1 months) (p = 0.002), with BIPAP (48.4 months)
(p = 0.001) and full face mask (61.5 months) or nasal
cannula (60.5 months) (p = 0.001).
A comparison was also made between two age groups:
younger than 12 months (infants) and older than
12 months (children) (Table 2).Fig. 1 Evolution in the use of non-invasive ventilation (NIV) (percentage ofThe need for IMV was similar in both age groups, but
infants required NIV more frequently. CPAP was the
most common modality in infants and BIPAP in the
older children. The “nasopharyngeal tube” was used
mostly in infants and nasal cannula in older children.
Duration of IMV and PICU LOS was significantly
higher in infants. There were no significant differences
in the duration of NIV between both age groups.Non invasive mechanical ventilation failure
41 patients (20.5%) treated with NIV required intub-
ation. 11 (5.5%) for different procedures and 30 (15%)
due to NIV failure, caused by ARF in 86.7% of them and
by hemodynamic instability in 13.3%.
Diaphragmatic paralysis was present in one third of
the patients in which NIV failed (10 patients).
NIV failure was greater in patients that had not
received IMV prior to NIV, in those intubated for ARF,
in those with BIPAP and in those requiring several inter-
faces, nasal mask or full face mask (Table 3).
The median duration of NIV was shorter in those
patients in which NIV failed (2 days, IQR 0.88–3) than
in those in which NIV was effective (3 days, IQR 2–5)
(p = 0.002). PICU LOS was longer in patients with NIV
failure (26.5 days, IQR 17.75–40.25) than in those with
NIV success (14.0 days, IQR 7–25) (p < 0.001).Discussion
Mechanical ventilation modifies lung pressures and vol-
umes affecting preload, afterload, contractility and heart
rate. Positive airway pressure may reduce pulmonary vascu-
lar resistance if it achieves appropriate alveolar recruitment
and it diminishes left ventricle afterload by increasing trans-
mural pressure. On the other hand, it decreases right
ventricle preload and it increases its afterload [9].
On the counterpart, IMV increases the risk of airway
damage, lung injury and infection and it is associated
with a longer PICU LOS [10].patients with NIV)







- 2001–2006 54.1% (279) 41.9% (176) <0.001
- 2007–2012 45.9% (236) 58.1% (244)
IMV 97.6% (488) 95.2% (400) 1.0
NIV 26.7% (138) 14.8% (62) <0.001
NIV only 5.2% (27) 4.9% (20) 0.107
NIV indication
- Prophylactic 71.7% (99) 56.4% (35) 0.026
- Acute respiratory failure 28.2% (39) 43.5% (27)
NIV type
- CPAP 84.0% (116) 24.2% (15) <0.001
- BIPAP 16.0% (22) 75.8% (47)
Interface
- Nasopharyngeal tube 84.0% (116) 25.8% (16) <0.001
- Nasal mask 2.2% (3) 6.5% (4)
- Full face mask 0% 11.3% (7)
- Nasal cannula 13.8% (19) 64.5% (40)a
NIV failure 18.8% (26) 24.2% (15) 0.247
Mortality 4.7% (24) 2.9% (12) 0.104
Median (IQR) Median (IQR)
IMV days 3.0 (1.0–8.0) 1.0 (0.4–4.0) <0.001
NIV days 3.0 (1.0–5.0) 2.0 (1.0–6.) 0.572
PICU LOS (days) 8.0 (5.0–16.7) 5.0 (3.0–12.0) <0.001
NIV GROUP
IMV days 8.0 (4.0–16.75) 9.0 (3.0–16.0) 0.9
PICU LOS (days) 16.0 (8.0–27.7) 15.5 (9.0–31.0) 0.9
BIPAP bilevel positive airway pressure, CPAP continuous positive airway
pressure, IMV invasive mechanical ventilation, NIV non-invasive ventilation,
PICU LOS pediatric intensive care unit length of stay
aThe sum of the patients older than 12 months with different interfaces is 67
instead of 62 because 5 of these patients had several interfaces
Table 3 NIV failure according to IMV prior to NIV, indication
and type of NIV
NIV failure (%) p
IMV prior to NIV
Yes 22/134 (16.4%) 0.046
No 19/66 (28.7%)
Indication
Prophylactic 22/134 (16.4%) 0.046
Respiratory failure 19/66 (28.7%)
Modality
CPAP 20/131 (15.2%) 0.016
BIPAP 21/69 (30.4%)
BIPAP bilevel positive airway pressure, CPAP continuous positive airway
pressure, IMV invasive mechanical ventilation, NIV non-invasive ventilation
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ical ventilation-related complications and it minimizes
the undesired effects on heart function [11].
NIV decreases the risk of mechanical ventilation-
related complications while maintaining the beneficial
heart and lung effects of positive airway pressure, enab-
ling an earlier extubation [12–14]. Nevertheless, very
few studies analyze the utility of NIV in the postopera-
tive period of heart surgery in adults [2, 3] or children
[14–16]. Our study is the first one to analyze NIV after
heart surgery in children over a long period.
Our study shows that the use of IMV has decreased as
the use of NIV has increased in our unit. This has not
affected the incidence of NIV failure. The use of BIPAP,
which offers greater respiratory support, as well as the
use of nasal cannula (which are comfortable and welltolerated) has increased throughout the study, while the
use of nasal and full-face masks has been reserved for
patients with a more severe ARF.
Some of the most important factors for the success of
NIV are the good tolerance and acceptance of the tech-
nique on behalf of the patients as well as an increasing
experience of the PICU team.
Infants require longer mechanical ventilation and their
need for NIV was greater than that of older children.
This fact has been described in previous studies [6, 7]. It
may be due to the greater complexity of the underlying
heart disease and the surgery, to their greater metabolic
requirements or to their greater dependence on dia-
phragmatic muscles (which can become impaired after
heart surgery).
The indication for NIV was prophylactic after extuba-
tion in most of our patients for having ARF or heart
failure risk factors [16]. It was not possible to analyze
the efficacy of NIV in reducing the risk of failure and in-
tubation due to the characteristics of our study. Our
percentage of NIV failure is consistent with what has
been published by other authors [13, 16]. We are not
able to answer the question of why NIV failure is greater
with BIPAP due to the retrospective nature of our study.
An important finding of our study is that the incidence
of NIV failure remains stable even though overall use of
NIV has significantly increased, and particularly in
patients with respiratory distress. Thus, we think that
patients that would have required intubation and mech-
anical ventilation in the first study period were
successfully treated with NIV in the second period of
the study.
This is why prospective comparative studies are
required to assess whether prophylactic NIV after extu-
bation decreases the incidence of ARF and re-intubation
in children after heart surgery.
Patients requiring NIV had longer PICU LOS than
those requiring only IMV, which could be misinterpreted
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during the late study period, as did the LOS, IMV dur-
ation and the use of BIPAP. RACHS Score only takes
into account surgical complexity, but not the severity of
the patient’s condition before and after surgery. Even so,
RACHS score and the number of heart transplants was
higher for patients requiring NIV in the second period
of the study (although not statistically significant). All
these facts may reflect an increase in the complexity and
severity of illness in the second period of the study.
Our study has several limitations: it is a retrospective
review including patients with a wide variety of heart
diseases. Thus, the presence of certain risk factors affect-
ing the need for and duration of mechanical ventilation,
PICU LOS and mortality were not studied, such as
comorbidity or changes in postoperative care [17]. The
parameters and complications of NIV were not regis-
tered either [18].
Conclusions
NIV is increasingly being used in the postoperative
period of heart surgery in our center with an 85% suc-
cess rate and is associated with a lesser need for IMV.
CPAP was the most common modality and the “naso-
pharyngeal tube” was the most common interface in our
study although, in the latter years, the use of BIPAP and
nasal cannula has increased significantly. Prospective
multicenter studies are needed to better assess the asso-
ciation of NIV and the need for mechanical ventilation,
PICU LOS and mortality.
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